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HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Requirement of  and  subunit transmembrane helix separation for integrin
outside-in signaling
Jieqing Zhu,1 Christopher V. Carman,2 Minsoo Kim,3 Motomu Shimaoka,4 Timothy A. Springer,1 and Bing-Hao Luo1
1The CBR Institute for Biomedical Research and Department of Pathology, Harvard Medical School, 2Beth Israel Deaconess Medical Center, Department of
Medicine, Harvard Medical School, Boston, MA; 3Division of Surgical Research, Rhode Island Hospital, Brown University School of Medicine, Providence; 4The
CBR Institute for Biomedical Research and Department of Anesthesia, Harvard Medical School, Boston, MA
Adhesion to extracellular ligands through
integrins regulates cell shape, migration,
growth, and survival. How integrins trans-
mit signals in the outside-to-in direction
remains unknown. Whereas in resting
integrins the  and  subunit transmem-
brane domains are associated, ligand
binding promotes dissociation and sepa-
ration of these domains. Here we address
whether such separation is required for
outside-in signaling. By introduction of
an intersubunit disulfide bond, we gener-
ated mutant integrin IIb3 with blocked
transmembrane separation that binds li-
gand, mediates adhesion, adopts an ex-
tended conformation after ligand binding,
and forms antibody-induced macroclus-
ters on the cell surface similarly to wild
type. However, the mutant integrin exhib-
its a profound defect in adhesion-induced
outside-in signaling as measured by cell
spreading, actin stress-fiber and focal
adhesion formation, and focal adhesion
kinase activation. This defect was res-
cued by reduction of the disulfide bond.
Our results demonstrate that the separa-
tion of transmembrane domains is re-
quired for integrin outside-in signal trans-
duction. (Blood. 2007;110:2475-2483)
© 2007 by The American Society of Hematology
Introduction
Integrins constitute a family of heterodimeric cell surface
adhesion receptors capable of transmitting bidirectional signals
across the plasma membrane. Inside-out signaling occurs when
specific intracellular signals impinge on integrin cytoplasmic
domains, triggering changes in conformation and ligand-binding
affinity in the extracellular domain. In turn, binding of extracel-
lular ligands produces intracellular signals (ie, outside-in sig-
nals) such as changes in tyrosine phosphorylation and cytoskel-
etal organization that critically influence cell shape, migration,
growth, and survival.1 The mechanism by which integrins
transmit outside-in signals, however, remains unknown.
Integrin  and  subunits each have a large extracellular
domain, a single transmembrane (TM) domain, and a short
cytoplasmic domain. In the resting state, in which integrins
exhibit low affinity for ligand, the extracellular domain exists in
a compact bent conformation2,3 that is stabilized by specific /
interfaces that exist in extracellular, TM,4 and cytoplasmic5,6
domains. Separation of the  and  TM and cytoplasmic
domains stimulated by physiologic inside-out activation signals,
overexpression of the talin head domain, or mutagenesis of
critical cytoplasmic or TM interface residues leads to conforma-
tional change in the extracellular domain.5,7-14 Alternatively,
stabilization of the cytoplasmic domain5 or TM domain inter-
faces4 blocks inside-out signal transduction. Such blockade can,
however, be readily circumvented by reagents such as activating
antibodies and Mn2, which act directly on the extracellular
domain to stabilize the high-affinity conformation,4,5 probably
because of the flexibility of the -subunit extracellular leg.15
It is widely believed that lateral association (ie, “clustering”) of
integrin heterodimers, which occurs as a consequence of multiva-
lent ligand binding,16,17 plays a major role in outside-in signaling
(see review18). However, what role, if any, integrin conformational
change (ie, separation of the TM and cytoplasmic domain inter-
faces) has in outside-in signaling remains uncharacterized.
In this study, we investigate outside-in signaling in the proto-
typic integrin IIb3 (platelet glycoprotein IIb-IIIa). IIb3 is
highly expressed on platelets and plays an essential role in
hemostasis, mediating platelet aggregation and spreading on vascu-
lar matrices. On resting platelets, IIb3 is inactive. When
stimulated by hemostatic agents, such as ADP or thrombin,
intracellular signals are generated that initiate IIb3 inside-out
signaling, resulting in transition to the high-affinity state and
binding of the ligands fibrinogen and von Willebrand factor.18 In
turn, binding to multivalent ligands by IIb3 induces outside-in
signals that initiate actin reorganization, shape change, and spread-
ing of platelets,18 as well as activation of specific nonreceptor
tyrosine kinases, such as focal adhesion kinase (FAK).19-24
Previously, it has been reported that integrin cross-linking and
clustering are required for outside-in signaling.25-28 It has also been
shown that activating mutations of the TM domains induced FAK
activation, but this was proposed to be due to integrin clustering,
thought to result from homomeric TM domain association.13 Here,
we investigate whether clustering is sufficient for outside-in
signaling, or whether integrin conformational change is also
required. We use a disulfide bond introduced into the exofacial
portion of the IIb and 3 TM interface to prevent the separation of
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the two TM helices. Our study demonstrates that the disulfide-
bonded mutant exhibits defective cell spreading, actin stress-
fiber and focal adhesion formation, and focal adhesion kinase
activation, despite intact ligand binding, adhesion, and antibody-
induced macroclustering. These results demonstrate that the
separation of the integrin  and  subunit TM domains is
required for integrin outside-in signaling.
Materials and methods
Plasmid construction and protein expression
Plasmids coding for full-length human IIb and 3 integrin subunits were
subcloned into pEF/V5-HisA and pcDNA3.1/Myc-His (), respectively.2
Single cysteine substitutions within the TM domains of IIb and 3 were
described previously.4 Constructs were transfected into CHO-K1 cells
(American Type Culture Collection, Manassas, VA) using Fugene (Roche
Diagnostics, Indianapolis, IN) transfection kit according to the manufac-
turer’s instructions. Stably transfected CHO cells were established as
described.29 The expression levels of IIb, 3, and the hamster V human
3 chimera were detected by flow cytometry staining with the monoclonal
antibodies 10E5 (anti-IIb mAb, kindly provided by B. S. Coller Rock-
efeller University, New York, NY),30 AP3 (nonfunctional anti-3 mAb;
American Type Culture Collection), and LM609 (anti-V3 mAb; Chemi-
con International, Temecula, CA), respectively. To characterize disulfide
formation, stably transfected cells were metabolically labeled with [35S]
cysteine/methionine and immunoprecipitated by anti-IIb mAb 10E5 as
described.4,5
Soluble ligand binding
The activating anti-aIIb mAb PT25–2 was a generous gift from M. Handa
(Keio University Hospital, Tokyo, Japan).31 Soluble binding of FITC-
labeled human fibrinogen (Enzyme Research Laboratories, South Bend, IN)
and ligand-mimetic PAC-1 IgM (Becton Dickinson, San Jose, CA) was
determined as described.29 Cells were also stained in parallel with anti-IIb
mAb 10E5 followed by FITC-conjugated anti–mouse IgG. Binding activity
is presented as the percentage of the mean fluorescence intensity (MFI) of
PAC-1 or fibrinogen staining relative to the MFI of 10E5 staining.
LIBS epitope expression
Anti–LIBS (ligand-induced–binding site) mAbs LIBS1 and D3 were kindly
provided by M. H. Ginsberg (University of California San Diego, La Jolla,
CA)32 and L. K. Jennings (University of Tennessee Health Science Center,
Memphis, TN).33 LIBS epitope expression was determined as described
previously.29 LIBS epitope expression was expressed as the percentage of
MFI of anti-LIBS antibody relative to the conformational-independent
anti-3 mAb AP3.
Cell adhesion
Cell adhesion on immobilized human fibrinogen was assessed by the
measurement of cellular lactate dehydrogenase (LDH) activity. Cells
suspended in 20 mM Hepes-buffered saline pH 7.4 (HBS) supplemented
with 5.5 mM glucose and 1% BSA, and either 1 mM Ca2/1 mM Mg2
or 1 mM Ca2/1 mM Mg2 plus 1 mM DTT, were preincubated with
10 g/mL mAb LM609 on ice for 30 minutes, and then seeded on
flat-bottom 96-well plates (104 cells/well) precoated with different
concentrations of fibrinogen and blocked with 1% BSA. After incuba-
tion at 37°C for 1 hour, wells were washed 3 times with HBS. The
remaining adherent cells were lysed by 1% Triton X-100, and LDH
activity was assayed using the Cytotoxicity Detection kit (LDH; Roche
Diagnostics, Penzberg, Germany) according to the manufacturer’s
instructions. Cell adhesion was expressed as a percentage of bound cells
relative to total input cells.
Cell spreading and microscopy
Cell spreading assays were carried out in Delta T imaging chambers
(Bioptechs, Butler, PA). The dishes were coated overnight at 4°C with
100 g/mL human fibrinogen or 20 g/mL PAC-1 in HBS, followed by
blocking with 1% BSA. The stably transfected cells were detached by
trypsin/EDTA, washed once with DMEM containing 0.5 mg/mL soybean
trypsin inhibitor (Calbiochem, La Jolla, CA), and then washed twice with
DMEM. Cells were incubated in suspension on ice for 30 minutes in
DMEM containing 10 g/mL mAb LM609 before seeding on fibrinogen-
coated dishes. Alternately, cells were seeded on PAC-1–coated dishes
without prior LM609 treatment. In indicated experiments, 1 mM DTT was
added concomitant with cell seeding. After incubation at 37°C for 1 hour,
cells were washed 3 times with phosphate-buffered saline at pH 7.4 (PBS)
and fixed with 3.7% formaldehyde in PBS at room temperature (RT) for
5 minutes. The fixed cells were treated with 5% nonfat dry milk in PBS at
RT for 10 minutes to block nonspecific binding and immunostained with
20 g/mL Alexa Fluor 488–conjugated anti-IIb mAb PT25–2 in PBS
containing 5% nonfat dry milk at RT for 30 minutes. After PT25–2 staining,
cells were washed 3 times with PBS and permeablized with 0.05% Triton
X-100 in PBS at RT for 10 minutes, followed by blocking with 5% nonfat
dry milk in PBS at RT for 10 minutes, and then stained with Alexa Fluor
546–conjugated phalloidin (Molecular Probes, Eugene, OR) or 20 g/mL
rabbit antivinculin (Sigma, St Louis, MO) in PBS containing 5% nonfat dry
milk at RT for 30 minutes. For vinculin staining, cells were finally
stained with 20 g/mL Alexa Fluor 546–labeled goat anti–rabbit IgG
(Molecular Probes).
Differential interference contrast (DIC) imaging was conducted on an
Axiovert S200 epifluorescence microscope (Carl Zeiss MicroImaging,
Heidelberg, Germany), using a 63/1.4 NA oil objective, coupled to a
Hamamatsu Orca CCD camera (Okayama City, Japan). For the quantifica-
tion of cell spreading, outlines of at least 100 adherent cells (from randomly
selected fields in each of 3 separate experiments) were generated and the
number of pixels contained within each of these regions was measured
using OpenLab software (Improvision, Lexington, MA). Confocal imaging
was performed with a Bio-Rad Radiance 2000 laser-scanning confocal
system (Hercules, CA) coupled to an Olympus BX50WI microscope
(Melville, NY) with a 100/1.0 NA water-immersion objective.
Antibody-induced integrin clustering
Stably transfected CHO-K1 cells were cultured in DMEM containing
10% FBS on Delta T dishes overnight at 37°C in a CO2 incubator. Adherent
cells were washed with PBS and incubated with 10 g/mL noninhibitory
anti-IIb3 mAb D57 (kindly provided by Dr M. H. Ginsberg) in PBS
containing 1% BSA for 30 minutes at 37°C, followed by staining
with 10 g/mL goat anti–mouse IgG conjugated to Alexa Fluor 488 for
30 minutes at 37°C. Cells were washed 3 times with PBS and fixed with
3.7% formaldehyde in PBS at RT for 5 minutes before confocal microscopy.
Alternatively, cells were fixed with 3.7% formaldehyde in PBS at RT for
5 minutes prior to anti-IIb3 mAb D57 and goat anti–mouse IgG staining.
Immunoprecipitation and Western blotting
Cells were allowed to spread at 37°C for 1 hour on fibrinogen (100 g/mL)–
coated or control (BSA)–coated 10-cm Petri dishes in the presence or
absence of 1 mM DTT. After washing with ice-cold PBS, cells were lysed
with 1 mL lysis buffer (50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.25% sodium
deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM Na3VO4, 1 mM NaF, and
1 g/mL each aprotinin, leupeptin, and pepstatin) on ice for 30 minutes.
The cell lysates were centrifuged at 4°C at 20 000g for 30 minutes and each
1 mL supernatant containing 500 g total proteins was subjected to
immunoprecipitation with 3 g anti-FAK mAb (BD Bioscience, San Jose,
CA) for 1 hour at 4°C followed by incubation with 25 L protein A agarose
(Invitrogen, Frederick, MD) for 1 hour at 4°C. The immunoprecipitated
proteins were eluted with 25 L Tris-glycine sodium dodecyl sulfate (SDS)
sample buffer and 10 L of each sample was subjected to SDS–
polyacrylamide gel electrophoresis (PAGE) and Western blotting. The
membrane was blotted with rabbit antiphospho-FAK (Tyr397) (Upstate,
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Lake Placid, NY) and reblotted with anti-FAK mAb (BD Bioscience). To
detect protein phosphotyrosine in total cell lysates, supernatants of cell
lysates containing 10 g proteins were subjected to SDS-PAGE and
Western blotting. The membranes were blotted with antiphosphotyrosine
mAb 4G10 (Upstate) and PY20 (BD Biosciences) and reblotted with
anti–-actin mAb (Sigma). Immunoreactive bands were detected by
enhanced chemiluminescence (ECL) Plus Western blotting detection re-
agents (Amersham Biosciences, Arlington Heights, IL) and scanned on a
Storm 860 Imager (GE Healthcare, Piscataway, NJ). The intensities of
bands of interest were quantified using ImageQuant software (GE Health-
care). The tyrosine phosphorylation of FAK was expressed as the phospho-
FAK (pY397) signal as a percentage of the total FAK signal.
To study the effect of antibody-induced integrin clustering on FAK
activation, stably transfected CHO-K1 cells suspended in 0.5 mL HBS
supplemented with 5.5 mM glucose and 1% BSA, and 1 mM Ca2/1 mM
Mg2 were incubated with or without 10 g/mL anti-IIb3 mAb D57 at
37°C for 30 minutes, followed by incubation with or without 10 g/mL
goat anti–mouse IgG for 60 minutes at 37°C. As a control, cells were
incubated with ligand-mimetic PAC-1 IgM in the presence of 1 mM Mn2
and 10 g/mL activating mAb PT25–2. After incubation, cells were washed
with ice-cold PBS and lysed with lysis buffer. The supernatants (500 g of
proteins) of cell lysates were precleared by incubation with 50 L protein A
agarose at 4°C for 1 hour, and then FAK was immunoprecipitated as
described in the previous paragraph. Tyrosine phosphorylation of FAK was
detected by antiphosphotyrosine mAb 4G10.
Results
Expression and disulfide bond formation of the wild-type and
mutant IIb3 receptors
Disulfide bond scanning studies have revealed in the resting
state a specific interface between the alpha-helices of the IIb
and 3 TM domains.4 For several pairs of cysteines introduced
at the exofacial region of the interface, disulfides form constitu-
tively.4 We focused on one of these (IIbW968C/3I693C,
denoted 968C/693C) that forms disulfides with approxi-
mately 100% efficiency to study its effect on integrin outside-in
signaling. CHO-K1 cells have been widely used to study IIb3
outside-in signaling.21,22,34 We generated stable CHO-K1 cell
lines expressing either wild-type (WT) or disulfide mutant
(968C/693C) IIb3. Stable WT and 968C/693C CHO
clones were selected that expressed similar levels of receptors,
as assessed by staining with anti-IIb monoclonal antibody
(mAb) 10E5 and anti-3 mAb AP3 (Figure 1A). Disulfide bond
formation between 968C and 693C was confirmed to be
approximately 100% by nonreducing SDS-PAGE of 35S-labeled,
10E5-immunoprecipitated receptors in the 968C/693C stable
CHO-K1 cell line (Figure 1B).
It is known in CHO cells that transfected human 3 integrin can
associate with the endogenous hamster V to form chimeric V3.
The chimeric V3 is also a receptor for fibrinogen35 but does not
bind the IIb3 ligand-mimetic mAb PAC-1. We confirmed, using
the anti-V3 complex-specific mAb LM609, that chimeric V3
was expressed along with IIb3 in both WT and 968C/693C
CHO-K1 cell lines (Figure 1A). In this context, V3 was found to
make a minor contribution to the overall adhesion to fibrinogen,
which could be completely blocked by the V3 function-blocking
antibody LM609 (Figure S1, available on the Blood website; see
the Supplemental Materials link at the top of the online article).
Thus, to exclude possible contribution of V3 outside-in signal-
ing, we have included LM609 in all fibrinogen-binding experiments.
TM disulfide-bonded IIb3 mediates externally stimulated
soluble ligand binding and cell adhesion similarly
to that of wild type
Whereas neither WT- nor 968C/693C-expressing cells bound
significant soluble fibrinogen (50 g/mL) or IIb3 ligand-
mimetic mAb PAC-1 (10 g/mL) in the presence of 1 mM Ca2,
both cell types efficiently bound these ligands in the presence of
activating cation (Mn2) or activating antibody (anti-IIb mAb
PT25–2)31 (Figure 2A). Ligand binding by both cell lines was
augmented even further by combined addition of Mn2 and
PT25–2.29 Treatment with reducing agent (1 mM DTT) slightly
increased ligand binding in Ca2 for both WT and 968C/
693C cells (Figure 2A). Most importantly, under all conditions
tested, ligand binding of the mutant 968C/693C was similar
to that of the WT. This suggests that the TM disulfide had little
effect on ligand binding stimulated from outside the cells by
Mn2 or activating mAbs. Similar results were obtained in 293T
cells transiently transfected with the WT and 968C/693C
mutant IIb3 (data not shown and see Luo et al4).
The ligand binding of the WT and disulfide mutant was further
assessed by cell adhesion assays on immobilized fibrinogen. As we
previously observed29 and in contrast to soluble ligand binding, at
coating concentrations higher than 1 g/mL both WT and 968C/
693C cells mediated efficient adhesion to immobilized fibrinogen even
in the absence of activation (ie, Mn2 or PT25–2) (Figure 2B). As a
negative control, parent CHO-K1 cells showed no adhesion even at the
highest coating concentration of fibrinogen (10 g/mL) (Figure 2B).
Treatment of WT and 968C/693C cells with 1 mM DTT had little
effect on cell adhesion for both WT and mutant integrins (Figure 2B), as
was the case for soluble ligand-binding assays (Figure 2A).
Figure 1. Expression and disulfide bond formation
of IIb3 integrins on CHO-K1 cells. (A) Immunofluo-
rescence flow cytometry of CHO-K1 transfectants.
CHO-K1 cells stably transfected with the wild-type (WT) or
cysteine mutant (968C/693C) IIb3 integrin were
immunostained with 10E5 (anti-IIb), AP3 (anti-3), and
LM609 (anti-V3 complex) and detected by flow cytom-
etry (––). Mock-transfected CHO-K1 cells were used as a
control. Cells immunostained with X63 control IgG are
shown (----). (B) Immunoprecipitation. Lysates from (35)S-
labeled CHO-K1 stable transfectants were immunoprecipi-
tated with mAb 10E5 (anti-IIb). The precipitates of WT or
968C/693C mutant were treated with nonreducing or
reducing loading buffer and subjected to 7.5% SDS-
PAGE. Bands of IIb (), 3 (), and IIb/3 (/)
heterodimer are indicated. Positions of protein molecular
size markers (in kDa) are shown on the left.
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TM disulfide-bonded IIb3 adopts an extended conformation
after binding to ligand
Previously, we demonstrated that disulfide-bonded receptor 968C/
693C adopted an extended conformation upon binding to an RGD
peptide, as determined by flow cytometry staining with anti-LIBS
antibodies.4 Here, we further investigated integrin conformation by
determining LIBS expression in the presence of human fibrinogen
(3 mg/mL). As expected, binding of RGD significantly increased
the staining of 2 anti-LIBS antibodies, D3 and LIBS1, in both
WT and 968C/693C CHO-K1 cells. The presence of fibrino-
gen also substantially increased the staining (Figure 2C). The
data demonstrate that the disulfide-bonded receptors could
adopt an extended conformation upon binding physiological
ligand even though the TM helices were associated. This is
consistent with previous observations that, due to flexibility of
the lower  leg, the linkage between TM domain separation and
integrin extension is not rigid.15
Integrin TM separation is critical for cell spreading
To assess efficiency of spreading, CHO-K1 transfectants were
allowed to adhere to immobilized fibrinogen or ligand-mimetic
antibody PAC-1 at 37°C for 1 hour, followed by fixation and
microscopic analysis. WT IIb3-expressing cells were found to
undergo substantial spreading on both substrates (Figure 3A).
However, despite strong binding and adhesion to these substrates
(Figure 2), cells expressing mutant 968C/693C exhibited little
or no spreading and instead remained rounded (Figure 3A).
Quantification of cell area revealed that, compared with controls
(cells fixed in suspension prior to settling on the substrates), WT
IIb3 transfectants increased their surface area by greater than
200% on average, whereas mutant IIb3 transfectants failed to
spread (Figure 3B). Similar results were obtained when the cell
spreading assay was carried out in the presence of Mn2 and
activating antibody (data not shown).
To demonstrate that the defect in spreading was due to the
TM disulfide linkage, we treated the cells with 1 mM DTT. This
resulted in reduction of the majority of engineered disulfides in
the mutant receptor, as seen by SDS-PAGE (Figure 3C). Such
reversal of the TM linkage led to a rescue of mutant IIb3
CHO spreading on fibrinogen and PAC-1 (Figure 3A,B). The
effect of DTT treatment was unlikely to be due to direct effect
on ligand binding because DTT could only slightly increase
ligand binding for both the WT and the mutant receptors (Figure
2) and DTT had little effect on cell spreading for the WT (Figure
3A,B). These data show that failure of mutant receptors to
support spreading on immobilized ligands was due specifi-
cally to the inability to undergo separation of the  and 
subunit TM helices.
The above results were supported by experiments using tran-
sient transfection of either 293T or CHO-K1 cells with the WT or
mutant receptors. In this setting, cells expressing WT or the single
cysteine mutant receptors (968C/3 and IIb/693C) spread
efficiently on immobilized fibrinogen. By contrast, 293T or CHO-K1
cells transiently expressing the disulfide mutant 968C/693C
failed to spread (Figure S2 and data not shown). Moreover, 293T
cells expressing 2 other mutants with disulfides introduced to the
C-termini of the IIb3 extracellular domain to prevent integrin
TM separation, IIbL959C/3P688C and IIbA958C/3E686C,
were also defective in spreading (data not shown). These results
demonstrate that the observed spreading defects were not cell-type
specific or due to specific effects of cysteine point mutations.
Integrin TM separation is important for focal adhesion and
actin stress-fiber formation
Ligand binding, and the resulting outside-in signaling by
integrins, is strongly coupled to cytoskeleton rearrangements
including formation of focal adhesion and actin stress fibers.36-38
Focal adhesions are initiated with the recruitment of integrins
into elongated, micron-scale macroclusters associated with the
substrate.35 To assess focal adhesion formation, CHO-K1 trans-
fectants were allowed to adhere to fibrinogen-coated substrates




















































































































Figure 2. Ligand binding and LIBS exposure. (A) Soluble fibrinogen (Fg) or PAC-1 binding of CHO-K1 stable transfectants in the presence of either 1 mM Ca2/1 mM Mg2,
1 mM Mn2, 10 g/mL PT25–2 plus 1 mM Ca2/1 mM Mg2, 10 g/mL PT25–2 plus 1 mM Mn2, or 1 mM DTT plus 1 mM Ca2/1 mM Mg2 as indicated. Binding activity was
determined by flow cytometry and expressed as described in “Soluble ligand binding.” (B) Adhesion of CHO-K1 transfectants (preincubated with 10 g/mL mAb LM609) in the
presence of 1 mM Ca2/1 mM Mg2 or 1 mM Ca2/1 mM Mg2 plus 1 mM DTT to surfaces coated with fibrinogen at indicated concentrations. The amount of bound cells was
determined by measuring the lactate dehydrogenase (LDH) activity as described in “Cell adhesion.” Data are representative of 3 independent experiments, each in triplicate.
(C) LIBS exposure. Cells were stained with 2 anti-LIBS antibodies, D3 and LIBS1, in the presence or absence of 50 M RGD peptides (GRGDSP) or 3 mg/mL human fibrinogen
in 1 mM Ca2/1 mM Mg2 condition. LIBS epitope expression was expressed as the percentage of mean fluorescence intensity of anti-LIBS antibody relative to the
conformational-independent anti-3 mAb AP3. Error bars are standard deviation (SD).
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vinculin antibodies. Under these conditions WT integrins could
be readily detected in clustered patterns that colocalized with
vinculin typical of focal adhesions, whereas 968C/693C
receptors showed no detectable focal adhesion formation (Fig-
ure 4). Consistent with the above results, DTT treatment
resulted in spreading and focal adhesion formation in the mutant
cells (Figure 4). However 1 mM DTT did not completely restore
the mutant cells to the WT levels, which was probably due to
incomplete reduction of the disulfide bond as shown in Figure
3C. Although higher concentration of DTT ( 5 mM) could
completely reduce the engineered disulfide, such conditions
produced secondary effects, including significantly increased
integrin affinity for ligands (data not shown), that precluded
meaningful interpretation in this setting.
To assess actin stress-fiber formation, fibrinogen-adherent cells
were prepared as above and stained with fluorescent phalloidin to
visualize F-actin. Focal contacts were concomitantly visualized by
staining integrins with fluorescent antibody. In cells expressing WT
IIb3, robust actin stress fibers were observed that colocalized
with integrin-enriched focal contacts at their termini (Figure 5).
Consistent with the assessment of focal adhesions, cells expressing
TM disulfide-bonded IIb3 failed to exhibit significant stress-
fiber formation (Figure 5). However, after DTT treatment, the actin
stress fibers, as well as cell spreading and colocalization of integrin
and actin, in mutant CHO-K1 cells were detected (Figure 5). These























































Figure 3. Cell spreading assay. (A) Differential interference contrast (DIC) images of CHO-K1 stable transfectants after adhering at 37°C to immobilized human fibrinogen
(in the presence of 10 g/mL mAb LM609) or ligand-mimic mAb PAC-1 in the presence or absence of 1 mM DTT. The images are representatives from 1 of 3 independent
experiments. Scale bar represents 10 m. (B) Quantification of the areas of adhering/spreading cells as described in “Cell spreading and microscopy.” Error bars are SD.
(C) Reduction of the disulfide bond by DTT. The (35)S-labeled transfectants were allowed to adhere on immobilized fibrinogen at 37°C for 1 hour in the presence or absence of
1 mM DTT, followed by immunoprecipitation with 10E5 (anti- IIb), and loaded on 7.5% SDS-PAGE under nonreducing condition. The bands corresponding to IIb (), 3 (),








Figure 4. Recruitment of IIb3 integrin at focal adhesion sites. Cells were allowed
to adhere on immobilized fibrinogen (in the presence of 10 g/mL mAb LM609) at
37°C for 1 hour in the presence or absence of 1 mM DTT, followed by fixation and
staining with antivinculin and anti-IIb mAb PT25–2 conjugated with Alexa Fluor 488
as described in “Cell spreading and microscopy.” The stained cells were subjected to
confocal microscopy. Scale bar represents 10 m.
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cytoskeleton signaling was blocked by the disulfide bond formed in
the TM domain.
Integrin TM separation is critical for adhesion-promoted
protein tyrosine phosphorylation
Activation of intracellular tyrosine phosphorylation is a central
component of integrin outside-in signaling.39 Thus, as another
measure of integrin outside-in signal transduction, we measured the
protein tyrosine phosphorylation in whole cell lysates from CHO-K1
cells expressing the WT or mutant integrins before and after
adhering to immobilized ligands. In cells transfected with WT
IIb3, adhesion to immobilized fibrinogen (at 37°C for 1 hour)
induced significant tyrosine phosphorylation of at least 3 proteins,
with molecular weights of approximately 66, 75, and 125 kDa
(Figure 6A). By contrast, there was no detectable increase of
protein tyrosine phosphorylation in 968C/693C-transfected cells
after adhering to fibrinogen. However, when 968C/693C-
transfected cells were treated with DTT, adhesion-dependent
increase in protein tyrosine phosphorylation of these 3 proteins was
detected (Figure 6A).
Among the many tyrosine kinases associated with integrin
signaling, focal adhesion kinase (FAK, a 125-kDa protein)
plays, perhaps, the most prominent role. Tyrosine phosphoryla-
tion of FAK itself (at residue Tyr397) is induced by integrin
signaling and is a reliable indicator of FAK activation status.40
Thus, FAK was immunoprecipitated from CHO cell transfec-
tants and Western blotting was performed using a well-known
anti-FAK antibody that recognizes the phosphorylated form of
Tyr397 specifically. As shown in Figure 6B,C, FAK became
strongly phosphorylated at Tyr397 in the WT IIb3 cells upon
adhesion to fibrinogen. However, there was little adhesion-
dependent increase of Tyr397 phosphorylation in the 968C/
693C cells (Figure 6B,C). After reducing the disulfide bond in
the mutant receptors with DTT, fibrinogen-dependent FAK
phosphorylation at Tyr397 was detected (Figure 6B,C). These
data demonstrate a critical role for TM domain separation for
integrin induction of intracellular tyrosine phosphorylation and,
specifically, activation of FAK.
Integrin macroclustering is not perturbed by
TM disulfide linkage
Activation of the full range of integrin-mediated signaling events
has been shown to require both receptor aggregation (clustering)
and occupancy (ligand binding).17,25-28 We demonstrated above that
wild-type and TM disulfide mutant integrins adhere to fibrinogen
substrates and undergo stimulated (via Mn2 or activating mAb)
binding to soluble ligand similarly (Figure 2A,B). Here we
assessed the overall capacity of wild-type and TM disulfide mutant
integrins to undergo cell surface redistribution and macrocluster-
ing. Antibody-mediated receptor cross-linking has been broadly








Figure 5. Actin stress-fiber formation in the stably transfected CHO-K1 cells
adhering on immobilized fibrinogen. Cells were seeded on fibrinogen-coated
surfaces (in the presence of 10 g/mL mAb LM609) and incubated at 37°C for 1 hour
in the presence or absence of 1 mM DTT. After fixation and permeabilization, the
adhering cells were stained with phalloidin conjugated with Alexa Fluor 546 and
anti-IIb mAb PT25–2 conjugated with Alexa Fluor 488. The stained cells were
subjected to confocal microscopy. Scale bar represents 10 m.
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Figure 6. Protein tyrosine phosphorylation after cell adhesion on immobilized
ligand. (A) Protein tyrosine phosphorylation in CHO-K1 cells stably transfected with
WT or mutant (968C/693C) IIb/3 after adhering to immobilized fibrinogen or
BSA (in the presence of 10 g/mL mAb LM609) in the presence or absence of 1 mM
DTT for 1 hour. Total cell lysates were blotted with antiphosphotyrosine mAb 4G10
and PY20 and reblotted with anti–-actin (lower panel). The arrows indicate the
position of 3 proteins that exhibited significantly increased phosphotyrosine signal
following adhesion on fibrinogen. Positions of protein molecular size marker (in kDa)
are shown on the left. (B) Tyrosine phosphorylation of focal adhesion kinase (FAK) in
the transfected CHO-K1 cells. Cells were adhered on fibrinogen or BSA-coated
culture dish for 1 hour followed by lysis. Lysates of adhering cells were immunoprecipi-
tated with anti-FAK mAb and blotted with anti-FAK (pY397) (rabbit antiserum) (upper
panel). The same membrane was then stripped and reblotted with anti-FAK rabbit
polyclonal IgG (lower panel). (C) Quantification of tyrosine phosphorylation of FAK.
The intensities of blotted phospho-FAK (Tyr397) and total FAK were quantified as
described in “Immunoprecipitation and Western blotting.” The extent of FAK tyrosine
phosphorylation was expressed as a percentage of phospho-FAK (pY397) signals
relative to total FAK signals. Results are average of 3 independent experiments. Error
bars are SD.
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clustering.17,25 To determine whether the 968C/693C recep-
tors retained the ability to form macroclusters, we cross-linked
cell surface WT and 968C/693C IIb3 with primary and
secondary antibodies at 37°C for 30 minutes followed by
fixation (Figure 7Aii). As a control, cells were fixed before
adding secondary antibody (Figure 7Ai). Confocal microscopy
revealed that upon cross-linking, but not under control condi-
tion, WT and mutant receptors both readily formed macroclus-
ters to a similar extent (Figure 7A). These results suggested that
the mutant 968C/693C receptors were not defective in their
overall capacity to undergo cell-surface redistribution and to
macrocluster upon interaction with multivalent ligand/substrate.
To study the signaling events mediated by antibody-induced
macroclustering, FAK tyrosine phosphorylation was measured
using cells in suspension on which IIb3 integrins were cross-
linked with primary and secondary antibodies. As shown in Figure
7B, cross-linking with a nonfunctional antibody (ie, non–
conformation dependent/altering, non–ligand mimetic) did not
induce detectable FAK tyrosine phosphorylation either in WT or
mutant cells (lanes 2,3). By contrast, binding of ligand-mimetic
PAC-1 (mouse IgM) induced obvious FAK tyrosine phosphoryla-
tion in WT cells, but not in mutant cells (Figure 7B lane 4).
PAC-1–induced FAK phosphorylation was, however, recovered in
the mutant integrin when treated with DTT (data not shown). These
results are consistent with the above assay using adherent cells (ie,
Figure 6B,C). As a positive control, WT cells or mutant cells
treated with DTT, which adhered to immobilized fibrinogen,
induced FAK phosphorylation (Figure 7B lane 5). These results
indicate that both integrin clustering and TM domain separation are
important for outside-in signaling.
Discussion
Cell membrane receptors transmit signals across the plasma
membrane by mechanisms that are still poorly understood. Activa-
tion of the full range of integrin-mediated signaling events has been
shown to require both receptor aggregation (clustering) and ligand
occupancy.26,27 However, a requirement for conformational change
in integrin outside-in signaling has not previously been demon-
strated. Moreover, the specific nature of any such conformational
change required for this process has not been identified. In this
study, we demonstrate that outside-in signaling is highly dependent
on the ability of integrins to undergo conformational rearrangement
and that signal transmission through the membrane requires
separation of the TM, and presumably, cytoplasmic domains.
We show that preventing TM domain separation by introducing a
disulfide bond between the  and  subunit TM domains, or between the
ectodomains adjacent to the TM domains, strongly inhibits ligand-
dependent outside-in signaling. Binding to soluble ligands required the
high-affinity integrin conformation and was not mediated by wild-type
and mutant IIb3 in the absence of stimulation. However, in the
presence of extracellular activation stimuli (ie, Mn2 and/or PT25–2
activating mAb) both the disulfide-linked and wild-type receptors bound
soluble ligands efficiently and to a similar extent. Contrasting to soluble
ligand binding, adhesion to multivalent substrates bearing immobilized
fibrinogen did not require activation. But importantly here again both
wild-type and mutant receptors behaved similarly and showed a
comparable dependence on the fibrinogen coating concentration. More-
over, both wild-type and disulfide-bonded receptors adopted an ex-
tended conformation upon ligand binding and were similarly susceptible
to antibody-induced cell surface redistribution (ie, macroclustering).
Nonetheless, as assessed by cell spreading, focal adhesion and actin
stress-fiber formation, and FAK tyrosine phosphorylation, the TM
disulfide bond greatly inhibited outside-in signal transduction. Impor-
tantly, single cysteine substitutions or reduction of the disulfide in the
double cysteine mutant rescued signaling, demonstrating that the
observed defects were not attributable to cysteine point mutations, but
rather to the restraint imposed by the disulfide bond. Thus, our results
demonstrate that outside-in signaling requires conformational communi-
cation between extracellular and cytoplasmic regions and specifically
requires TM domain separation.
Precisely how integrin TM domain separation is involved in the
outside-in signaling process remains to be determined. Based on
previous FRET studies,10 we assume that ligand-induced TM separation
is likely coupled to cytoplasmic domain separation, implying that -
cytoplasmic domain interactions somehow constrain or inhibit integrin
signaling capacity. Interestingly, and in support of this idea, chimeric
integrin  (1, 3, or 5) subunit cytoplasmic domains (coupled to an
unrelated TM and extracellular domain) expressed in the absence of 
subunit cytoplasmic domains were competent for signal transduction
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Figure 7. Antibody-induced integrin clustering and its effect on FAK
activation. (A) Confocal images of integrin clustering induced by antibody. The
stably transfected cells grown on Delta T dishes were stained with nonfunctional
anti-IIb3 mAb, followed by staining with goat anti–mouse IgG conjugated
with Alexa Fluor 488 after (i) or before (ii) fixation. Scale bar represents 10 m.
(B) WT or 968C/693C mutant CHO-K1 cell transfectants in suspension were
incubated with (lanes 2,3) or without (lane 1) noninhibitory anti-IIb3 mAb in the
absence (lane 2) or presence (lane 3) of goat anti–mouse IgG at 37°C for 1 hour.
As a control, cells were incubated with ligand-mimetic antibody PAC-1 (lane 4)
in the presence of 1 mM Mn2 and 10 g/mL activating antibody PT25–2 or
adhered on Fg-coated dish (lane 5) in the absence (for WT) or presence (for
968C/693C) of 1 mM DTT. FAK was immunoprecipitated from the cell lysate
and blotted with antiphosphotyrosine mAb 4G10 (FAK-pY) and reblotted with
anti-FAK (total FAK).




 http://ashpublications.org/blood/article-pdf/110/7/2475/484627/zh801907002475.pdf by guest on 05 O
ctober 2021
phosphorylation to levels comparable with those elicited by adhesion of
the endogenous integrins to ligand-coated substrates.41 It has been
known that many cytoplasmic proteins, including nonreceptor protein
tyrosine kinases, can bind integrin cytoplasmic tails.42 Thus, one
possibility is that ligand binding-induced separation of TM and cytoplas-
mic domains is required for kinases or other intracellular proteins to bind
integrin cytoplasmic tails. Several studies suggested that some proteins
(eg, talin7,14,43) bind to the integrin -subunit tail at the same location as
does the -subunit tail. In this context, dissociation of - and -subunit
tails would seem to be required for the binding of such proteins. On the
other hand, some studies have shown that certain tyrosine kinases, such
as Src, associate constitutively with integrin IIb3 in platelets, and
platelet adhesion to fibrinogen causes a rapid increase in Src activa-
tion.44 Thus, another possibility is that the association of the integrin TM
and cytoplasmic domains somehow constrains the activity of integrin
tail-bound kinases, whereas dissociation of the TM and cytoplasmic
domains releases these constraints.
An important role for integrin clustering has been well estab-
lished for outside-in signaling.25-28 Given that some outside-in
signaling (although not typically the full range of signaling events)
can be induced in certain settings by integrin cross-linking
strategies (eg, with nonfunctional antibodies), which themselves do
not proactively stabilize the active integrin conformation, it has
often been inferred that conformation does not play a direct or
critical role in such signaling. Importantly, however, in no such
studies has conformation been specifically controlled. It is now
well understood that integrins exist in a dynamic equilibrium
between various inactive and active conformational states; even in
the absence of specific stimuli (eg, inside-out signals or extracellu-
lar ligand), at any given instant some fraction of cell surface
integrins may spontaneously transition to intermediate or open
conformations.15 Although under our experimental conditions no
activation of FAK phosphorylation was observed upon cross-
linking with a nonfunctional integrin antibody, our results suggest
that in settings where signaling has resulted from such treatments,
that the resulting increase in density of the spontaneously active
conformers (with dissociated  and  cytoplasmic domains) is
responsible for activation. When integrin occupancy by soluble
monomeric ligand (which stabilizes the active integrin conformers
and promotes transmembrane domain separation) has been com-
bined with antibody cross-linking, total outside-in signal transduc-
tion is greatly elevated.26,27 This result is consistent with an
increase in the local density of active integrin conformers and our
finding that transmembrane domain separation is required for
integrin outside-in signaling. While dissociation of the  and 
cytoplasmic domains may be important for the association and/or
activity of specific kinases, clustering may serve to facilitate
interactions among integrin-bound kinases to promote transphos-
phorylation/transactivation events in a fashion loosely analogous to
receptor tyrosine kinase activation.
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